Section Arrow
LENZ.NASDAQ
- LENZ Therapeutics
Quotes are at least 15-min delayed:2026/04/22 03:20 EDT
Regular Hours
Last
 9.87
-0.26 (-2.57%)
Day High 
10.39 
Prev. Close
10.13 
1-M High
11.475 
Volume 
488.99K 
Bid
--
Ask
--
Day Low
9.815 
Open
10.12 
1-M Low
8.25 
Market Cap 
317.62M 
Currency 美元 
P/E -- 
%Yield 32.39 
10-SMA 9.66 
20-SMA 9.45 
50-SMA 11.33 
52-W High 50.4 
52-W Low 8.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.85/-0.61
Enterprise Value
317.97M
Balance Sheet
Book Value Per Share
9.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.09M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1968-0.0651-24.86%-- 
XRTXXORTX Therapeutics Inc.2.69+0.44+19.56%-- 
TOVXTheriva Biologics Inc0.3387-0.0713-17.39%0.09PE
GERNGeron Corp1.5-0.06-3.85%-- 
SPRCSciSparc Ltd.5.99+1.76+41.61%0PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.